Bridgewater bets $6.7 billion against European stocks

By Carolina Mandl

NEW YORK, June 16 (Reuters) - Bridgewater Associates has placed at least $6.7 billion in bets against European stocks, according to data group Breakout Point, in a sign that the hedge fund firm may be pessimistic about companies on the continent.

Using Bridgewater's public disclosures, Breakout Point calculated that the Connecticut-based fund has bet against 21 European companies so far this week, in sectors ranging from finance to energy. Among its biggest short bets are semiconductor-equipment supplier ASML Holding NV ASML.AS ($1 billion), energy company TotalEnergies SE TTEF.PA ($705 million) and drugmaker Sanofi SA SASY.PA ($646 million).

Banco Santander SA SAN.MC , BNP Paribas SA BNPP.PA and Banco Bilbao Vizcaya Argentaria SA BBVA.MC and Intesa Sanpaolo SpA ISP.MI are also in the list of Bridgewater's short positions, as well as insurance companies Allianz SE ALVG.DE , ING Groep NV INGA.AS and AXA SA AXAF.PA , according to Bridgewater.

"When it comes to magnitude of short-selling, we don't recall any other money manager coming close to this, except for Bridgewater itself," said Breakout Point, adding that the hedge fund founded by billionaire Ray Dalio had similar bets back in first quarter of 2018 and 2020.

Breakout Point used public disclosures to make calculations about Bridgewater short positions. Under European regulation, funds have to disclose bets over 0.5% short interest, which means Bridgewater's bets against European stocks could be bigger.

It is not clear, however, if those positions are a hedge against other bets. Bridgewater, which manages $150 billion in assets, did not immediately comment on the matter.

Bridgewater's bets become public in a week when central banks across Europe and in the United States raised interest rates to fight inflation, in a move that could tip economies into recession.

Newspaper Financial Times first reported on Bridgewater's bets against shares in European companies.

Reporting by Carolina Mandl; Editing by Lisa Shumaker

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.